ArticleMolecular oncology2015

Additive impact of HER2-/PTK6-RNAi on interactions with HER3 or IGF-1R leads to reduced breast cancer progression in vivo.

Natalie Falkenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.